News Conference News AHA 2023 Inflammation More Powerful Than LDL as CV Risk Predictor in Statin-Free Patients Caitlin E. Cox November 07, 2023
News Daily News Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs Michael O'Riordan July 11, 2023
News Daily News AI Gleans Insights Into Statin Questions, Misinformation Online L.A. McKeown April 26, 2023
News Conference News AHA 2022 Common ‘Heart’ Supplements Can’t Beat Statins: SPORT Michael O'Riordan November 06, 2022
News Daily News Homozygous FH Diagnosis Often Comes Late, With Lackluster Care Michael O'Riordan February 10, 2022
News Daily News Could an App Replace Statin Prescribing by Doctors? Michael O'Riordan September 08, 2021
News Daily News Obesity’s Role in COVID-19 Deaths: Big Food, Slow Government to Blame? Shelley Wood June 11, 2020
News Daily News Meat Consumption Linked to Small Rises in CVD, All-Cause Mortality Risks Michael O'Riordan February 05, 2020
News Conference News AHA 2019 COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine Caitlin E. Cox November 16, 2019
News Daily News Most Supplements and Diets Don’t Lower CVD or Mortality Risks Michael O'Riordan July 09, 2019
News Features The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine Shelley Wood October 22, 2018
News Daily News A Deadly Diet: Half of US Deaths From Cardiometabolic Causes Linked to Dietary Habits Michael O'Riordan March 08, 2017
News Daily News FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin Michael O'Riordan June 30, 2016
News Daily News Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER Michael O'Riordan June 14, 2016